October 2007
Red Herring;10/7/2007, Vol. 4 Issue 29, p52
Trade Publication
The article focuses on Saint Paul, Minnesota-based EnteroMedics, a technology company included in "Red Herring's" top 100 list for 2007. Mark Knudson is the chief executive officer (CEO) of the company, which has 51 employees. Some of its key investors are Mayo Foundation for Medical Foundation and Research, Bay City Capital and Aberdare Ventures. EnteroMedics is out to help people fight fat. The company's approach lies in an implantable device that blocks nerve signals between the brain, stomach, and pancreas--a trick it believes will help obese people drop weight. But EnteroMedics is not the only one with a weight-loss implant. To get its share of the market, EnteroMedics will have to prove its device's effectiveness is worth the risk.


Related Articles

  • Enrollment in EnteroMedics' ReCharge trial is complete. Pedersen, Amanda // Medical Device Daily;12/29/2011, Vol. 15 Issue 249, p1 

    The article reports on the completion of the enrollment phase and device implantation for EnteroMedics' ReCharge pivotal trial for its VBLOC vagal blocking therapy for obesity. VBLOC therapy is said to be a first-in-class weight loss treatment designed to control hunger and fullness through...

  • EnteroMedics Maestro fails to meet endpoints in clinical study. FORD, OMAR // Medical Device Daily;10/5/2009, Vol. 13 Issue 191, p1 

    The article presents the preliminary results of a study conducted by EnteroMedics of Saint Paul, Minnesota to evaluate the safety and effectiveness of the Maestro System in treating obesity. The results of the study failed to meet the primary and secondary efficacy endpoints of the company after...

  • VBLOC, safer weight-loss alternative than surgeries?  // Medical Technology & Devices Week;7/7/2008, Vol. 6 Issue 27, p3 

    The article reports on the development of an implantable device-based therapy called vagal blocking therapy (VBLOC) by Mayo Clinic with EnteroMedics in 2008. Said therapy is claimed to be a safer alternative to bariatric procedures for obese persons wanting to eliminate excess weight. The...

  • VBLOC blocks signals between brain and gut for weight loss. PEDERSEN, AMANDA // Medical Device Daily;1/27/2009, Vol. 13 Issue 16, p1 

    This article states that EnteroMedics of Saint Paul, Minnesota, has developed device it says will be an alternative to weight-loss surgery. EnteroMedics' technology is designed to slow down or even block the signals from the brain to the stomach and back again. The device is called VBLOC vagal...

  • VBLOC Therapy is CE-marked.  // Medical Device Daily;3/12/2009, Vol. 13 Issue 47, p3 

    The article reports on the CE-mark approval received by EnteroMedical covering its VBLOC Therapy. The therapy is used as a treatment of obesity and is delivered via the Maestro System. The system, as the company claims, is the first to treat obesity using neuroblocking technology and serves as a...

  • Why Bigger isn't Always Better. Engen, John // U.S. Banker;Feb2005, Vol. 115 Issue 2, p20 

    Focuses on a recent study which states that high investor returns do not correlate to larger market share. Analysis on the performance of the largest retail banking companies by the First Manhattan Consulting Group; Comment of Jim McCormick, founder and principal of FMCG, on the impact of having...

  • Ericsson: from B to A.  // MarketWatch: Global Round-up;April 2004, Vol. 3 Issue 4, p172 

    Reports on the plans of Ericsson AG to reform the controversial voting structure of the company in Sweden. Way of increasing the number of foreign investors; Expansion on the market share of the company; Level of competitive advantage.

  • Keep an eye on the fund professionals. Laurence, Michael // BRW;07/28/97, Vol. 19 Issue 28, p131 

    Comments on how personal share investors should take note of the strategies now being adopted by some of the market professionals. Management objectives; How personal investors can learn from the stances of market professionals; The use of captial-guaranteed share loans; Simplified summary of...

  • Share market recovery running out of steam. Beaman, Lucinda // Money Management;1/21/2010, Vol. 24 Issue 1, p4 

    The article presents a report from Wilson Asset Management (WAM) which shows that investors re-entering the share market might discover that the wide upward trajectory ended.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics